Works matching IS 19466234 AND DT 2022 AND VI 14 AND IP 631

Results: 6

Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunity.
Published in:
Science Translational Medicine, 2022, v. 14, n. 631, p. 1, doi. 10.1126/scitranslmed.abj6824
By:
- Riou, Catherine;
- Keeton, Roanne;
- Moyo-Gwete, Thandeka;
- Hermanus, Tandile;
- Kgagudi, Prudence;
- Baguma, Richard;
- Valley-Omar, Ziyaad;
- Smith, Mikhail;
- Tegally, Houriiyah;
- Doolabh, Deelan;
- Iranzadeh, Arash;
- Tyers, Lynn;
- Mutavhatsindi, Hygon;
- Tincho, Marius B.;
- Benede, Ntombi;
- Marais, Gert;
- Chinhoyi, Lionel R.;
- Mennen, Mathilda;
- Skelem, Sango;
- du Bruyn, Elsa
Publication type:
Article
Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals.
Published in:
Science Translational Medicine, 2022, v. 14, n. 631, p. 1, doi. 10.1126/scitranslmed.abi8961
By:
- Samanovic, Marie I.;
- Cornelius, Amber R.;
- Gray-Gaillard, Sophie L.;
- Allen, Joseph Richard;
- Karmacharya, Trishala;
- Wilson, Jimmy P.;
- Hyman, Sara Wesley;
- Tuen, Michael;
- Koralov, Sergei B.;
- Mulligan, Mark J.;
- Herati, Ramin Sedaghat
Publication type:
Article
Ebola virus persistence and disease recrudescence in the brains of antibody-treated nonhuman primate survivors.
Published in:
Science Translational Medicine, 2022, v. 14, n. 631, p. 1, doi. 10.1126/scitranslmed.abi5229
By:
- Liu, Jun;
- Trefry, John C.;
- Babka, April M.;
- Schellhase, Christopher W.;
- Coffin, Kayla M.;
- Williams, Janice A.;
- Raymond, Jo Lynne W.;
- Facemire, Paul R.;
- Chance, Taylor B.;
- Davis, Neil M.;
- Scruggs, Jennifer L.;
- Rossi, Franco D.;
- Haddow, Andrew D.;
- Zelko, Justine M.;
- Bixler, Sandra L.;
- Crozier, Ian;
- Iversen, Patrick L.;
- Pitt, Margaret L.;
- Kuhn, Jens H.;
- Palacios, Gustavo
Publication type:
Article
Activation of the sigma-1 receptor chaperone alleviates symptoms of Wolfram syndrome in preclinical models.
Published in:
Science Translational Medicine, 2022, v. 14, n. 631, p. 1, doi. 10.1126/scitranslmed.abh3763
By:
- Crouzier, Lucie;
- Danese, Alberto;
- Yasui, Yuko;
- Richard, Elodie M.;
- Liévens, Jean-Charles;
- Patergnani, Simone;
- Couly, Simon;
- Diez, Camille;
- Denus, Morgane;
- Cubedo, Nicolas;
- Rossel, Mireille;
- Thiry, Marc;
- Su, Tsung-Ping;
- Pinton, Paolo;
- Maurice, Tangui;
- Delprat, Benjamin
Publication type:
Article
Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency.
Published in:
Science Translational Medicine, 2022, v. 14, n. 631, p. 1, doi. 10.1126/scitranslmed.abg8070
By:
- Lahman, Miranda C.;
- Schmitt, Thomas M.;
- Paulson, Kelly G.;
- Vigneron, Nathalie;
- Buenrostro, Denise;
- Wagener, Felecia D.;
- Voillet, Valentin;
- Martin, Lauren;
- Gottardo, Raphael;
- Bielas, Jason;
- McElrath, Julie M.;
- Stirewalt, Derek L.;
- Pogosova-Agadjanyan, Era L.;
- Yeung, Cecilia C.;
- Pierce, Robert H.;
- Egan, Daniel N.;
- Bar, Merav;
- Hendrie, Paul C.;
- Kinsella, Sinéad;
- Vakil, Aesha
Publication type:
Article
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function.
Published in:
Science Translational Medicine, 2022, v. 14, n. 631, p. 1, doi. 10.1126/scitranslmed.abg8027
By:
- Ruggiero, Eliana;
- Carnevale, Erica;
- Prodeus, Aaron;
- Magnani, Zulma Irene;
- Camisa, Barbara;
- Merelli, Ivan;
- Politano, Claudia;
- Stasi, Lorena;
- Potenza, Alessia;
- Cianciotti, Beatrice Claudia;
- Manfredi, Francesco;
- Di Bono, Mattia;
- Vago, Luca;
- Tassara, Michela;
- Mastaglio, Sara;
- Ponzoni, Maurilio;
- Sanvito, Francesca;
- Liu, Dai;
- Balwani, Ishina;
- Galli, Rossella
Publication type:
Article

Works matching IS 19466234 AND DT 2022 AND VI 14 AND IP 631

Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunity.

Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals.

Ebola virus persistence and disease recrudescence in the brains of antibody-treated nonhuman primate survivors.

Activation of the sigma-1 receptor chaperone alleviates symptoms of Wolfram syndrome in preclinical models.

Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency.

CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function.